Medicare Enrolled
Dr. Javier Duron Tabora, MD
Endocrinology · Sparta, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Duron Tabora from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Duron Tabora?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Duron Tabora
Dr. Javier Duron Tabora is an endocrinology specialist in Sparta, NJ, with 9 years of NPI registration. Based on federal Medicare data, Dr. Duron Tabora performed 946 Medicare services across 658 unique beneficiaries.
Between the years covered by Open Payments, Dr. Duron Tabora received a total of $8,005 from 42 pharmaceutical and/or device companies across 481 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Duron Tabora is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 9 years in practice
▲ Top 47% volume in NJ
$8,005 industry payments
Medicare Practice Summary
Medicare Utilization ↗946
Medicare services
Top 47% in NJ for endocrinology
658
Unique beneficiaries
$43
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~105 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
227 | $84 | $175 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
109 | $10 | $35 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
95 | $16 | $55 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
85 | $9 | $30 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
77 | $115 | $275 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
67 | $9 | $35 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
46 | $5 | $24 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
41 | $40 | $130 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
39 | $6 | $19 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
34 | $13 | $50 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $64 | $120 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
27 | $29 | $95 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
21 | $79 | $195 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
19 | $5 | $15 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
14 | $7 | $25 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
13 | $79 | $170 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$8,005
Total received (2020-2024)
Avg $2,001/year across 4 years
Top 21% in NJ for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
481
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,958 (99.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$47 (0.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,440
2023
$3,472
2022
$1,066
2020
$27
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$309
Lilly USA, LLC
$272
Amgen Inc.
$267
SANOFI-AVENTIS U.S. LLC
$235
Bayer Healthcare Pharmaceuticals Inc.
$198
Corcept Therapeutics
$191
Radius Health, Inc.
$183
Boehringer Ingelheim Pharmaceuticals, Inc.
$180
Novo Nordisk Inc
$176
Insulet Corporation
$172
Mannkind Corporation
$152
Medtronic, Inc.
$147
Tandem Diabetes Care, Inc.
$139
Xeris Pharmaceuticals, Inc.
$123
Kyowa Kirin, Inc.
$88
Chiesi USA, Inc.
$69
BETA BIONICS, INC.
$64
Amphastar Pharmaceuticals, Inc.
$58
Dexcom, Inc.
$56
Esperion Therapeutics, Inc.
$55
RECORDATI_RARE_DISEASES_INC.
$55
ABBVIE INC.
$47
Alexion Pharmaceuticals, Inc.
$41
Ascensia Diabetes Care Us Inc.
$36
PFIZER INC.
$35
Amneal Pharmaceuticals LLC
$30
Neurocrine Biosciences, Inc.
$25
Verity Pharmaceuticals Inc.
$19
Rhythm Pharmaceuticals, Inc.
$16
Top 3 companies account for 24.7% of 2024 payments
All-time payments by company (2020-2024) ›
Lilly USA, LLC
$1,020
Novo Nordisk Inc
$809
Corcept Therapeutics
$539
Boehringer Ingelheim Pharmaceuticals, Inc.
$491
Amgen Inc.
$487
Bayer Healthcare Pharmaceuticals Inc.
$432
Medtronic, Inc.
$403
Novartis Pharmaceuticals Corporation
$403
Insulet Corporation
$383
SANOFI-AVENTIS U.S. LLC
$282
Radius Health, Inc.
$255
Horizon Therapeutics plc
$229
MannKind Corporation
$227
Kyowa Kirin, Inc.
$199
Tandem Diabetes Care, Inc.
$191
Xeris Pharmaceuticals, Inc.
$159
Mannkind Corporation
$152
RECORDATI_RARE_DISEASES_INC.
$143
Alexion Pharmaceuticals, Inc.
$107
Bayer HealthCare Pharmaceuticals Inc.
$95
Dexcom, Inc.
$93
PFIZER INC.
$82
AstraZeneca Pharmaceuticals LP
$81
Esperion Therapeutics, Inc.
$74
Chiesi USA, Inc.
$69
BETA BIONICS, INC.
$64
ABBVIE INC.
$63
Amphastar Pharmaceuticals, Inc.
$58
Ascensia Diabetes Care Us Inc.
$54
Amarin Pharma Inc.
$50
Merck Sharp & Dohme LLC
$47
Abbott Laboratories
$37
Kowa Pharmaceuticals America, Inc.
$32
AbbVie Inc.
$32
Amneal Pharmaceuticals LLC
$30
Supernus Pharmaceuticals, Inc.
$29
Neurocrine Biosciences, Inc.
$25
Verity Pharmaceuticals Inc.
$19
Rhythm Pharmaceuticals, Inc.
$16
Amryt Pharma Holdings Ltd
$16
Antares Pharma, Inc.
$13
Ultragenyx Pharmaceutical Inc.
$13
Top 3 companies account for 29.6% of all-time payments
Associated products mentioned in payments ›
AFREZZA · BAQSIMI · Crysvita · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FREESTYLE LIBRE 3 · GUARDIAN SENSOR (3) · GVOKE HYPOPEN · IMCIVREE · INPEN SMART INSULIN DELIVERY SYSTEM · ISTURISA · JARDIANCE · Kerendia · Korlym · LEQVIO · LIVALO · LYUMJEV · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYCAPSSA · NEXLETOL · NOCDURNA · Omnipod · Ozempic · RECORLEV · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STRENSIQ · SYNTHROID · Saxenda · TEPEZZA · TLANDO · TZIELD · Tlando · Tymlos · UBRELVY · UNITHROID · VERQUVO · Vascepa · Wegovy · iLet Bionic Pancreas · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Endocrinologists within 10 mi
40
Per 100K population
27.6
County median income
$114,316
Nearest hospital
NEWTON MEDICAL CENTER
9.1 mi
9.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Duron Tabora is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Duron Tabora experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Duron Tabora performed 227 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Duron Tabora receive payments from pharmaceutical companies?
Yes. Dr. Duron Tabora received a total of $8,005 from 42 companies across 481 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Duron Tabora's costs compare to other endocrinologists in Sparta?
Dr. Duron Tabora's average Medicare payment per service is $43. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Duron Tabora) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Sparta
Browse endocrinologists in Sparta ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NJ
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NJ
Which NJ endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Corcept Therapeutics Payments to Doctors
See all physicians who received payments from Corcept Therapeutics.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology